1 |
Poston JT, Koyner JL Sepsis associated acute kidney injury[J]. BMJ, 2019 (364): k4891.
|
2 |
Gómez H, Kellum JA. Sepsis-induced acute kidney in-jury[J]. Curr Opin Crit Care, 2016, 22 (6): 546-553.
|
3 |
曾小娜,尹连红,许丽娜. 脓毒症急性肾损伤发病机制[J]. 生理科学进展,2020,51(2):122-126.
|
4 |
Dennis JM, Witting PK. Protective role for antioxidants in acute kidney disease[J]. Nutrients, 2017, 9 (7): 718.
|
5 |
Jiang X, Liu Y, Ma L, et al. Chemopreventive activity of sulforaphane[J]. Drug Des Devel Ther, 2018 (12): 2905-2913.
|
6 |
董春霞,杨莉. AKI的流行病学:AKI的发生率、患者死亡率、肾脏死亡率[J]. 中国血液净化,2017,16(1):8-10.
|
7 |
刘颖,孟超,赵谊,等. 自噬蛋白Beclin1及炎症因子表达在脓毒症急性肾损伤中的作用[J/CD]. 中华危重症医学杂志(电子版),2020,13(6):401-405.
|
8 |
吴炆晓,张爱华. 线粒体功能障碍与脓毒症急性肾损伤的研究进展[J]. 中华肾脏病杂志,2020,36(4):327-331.
|
9 |
Peerapornratana S, Manrique-Caballero CL, Gómez H, et al. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment[J]. Kidney Int, 2019, 96 (5): 1083-1099.
|
10 |
葛勤敏,边帆,潘曙明. 脓毒症急性肾损伤研究进展[J]. 内科急危重症杂志,2016,22(6):460-463.
|
11 |
Podkowińska A, Formanowicz D. Chronic kidney dis-ease as oxidative stress- and inflammatory-mediated cardiovascular disease[J]. Antioxidants (Basel), 2020, 9 (8): 752.
|
12 |
Liguori I, Russo G, Curcio F, et al. Oxidative stress, aging, and diseases[J]. Clin Interv Aging, 2018 (13): 757-772.
|
13 |
Ho E, Karimi Galougahi K, Liu CC, et al. Biological markers of oxidative stress: applications to cardiovascular research and practice[J]. Redox Biol, 2013, 1 (1): 483-491.
|
14 |
Yatoo MI, Parray OR, Mir M, et al. Comparative e-valuation of different therapeutic protocols for contagious caprine pleuropneumonia in Himalayan Pashmina goats[J]. Trop Anim Health Prod, 2019, 51 (8): 2127-2137.
|
15 |
Basak P, Sadhukhan P, Sarkar P, et al. Perspectives of the Nrf-2 signaling pathway in cancer progression and therapy[J]. Toxicol Rep, 2017 (4): 306-318.
|
16 |
Liu P, Atkinson SJ, Akbareian SE, et al. Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3 / HIF-1α / VEGF signalling[J]. Sci Rep, 2017, 7 (1): 12651.
|
17 |
Ranaweera SS, Dissanayake CY, Natraj P, et al. Anti-inflammatory effect of sulforaphane on LPS-stimulated RAW 264.7 cells and ob / ob mice[J]. J Vet Sci, 2020, 21 (6): e91.
|
18 |
Pearson BL, Simon JM, McCoy ES, et al. Identification of chemicals that mimic transcriptional changes associated with autism, brain aging and neurodegeneration[J]. Nat Commun, 2016 (7): 11173.
|
19 |
Sun Y, Yang T, Mao L, et al. Sulforaphane protects against brain diseases: roles of cytoprotective enzymes[J]. Austin J Cerebrovasc Dis Stroke, 2017, 4 (1): 1054.
|
20 |
Nagata N, Xu L, Kohno S, et al. Glucoraphanin am-eliorates obesity and insulin resistance through adipose tissue browning and reduction of metabolic endotoxemia in mice[J]. Diabetes, 2017, 66 (5):1222-1236.
|
21 |
Brown RH, Reynolds C, Brooker A, et al. Sulfora-phane improves the bronchoprotective response in asthmatics through nrf2-mediated gene pathways[J]. Respir Res, 2015, 16 (1): 106.
|
22 |
Wu W, Peng G, Yang F, et al. Sulforaphane has a therapeutic effect in an atopic dermatitis murine model and activates the Nrf2 / HO-1 axis[J]. Mol Med Rep, 2019, 20 (2): 1761-1771.
|
23 |
Oh CJ, Kim JY, Min AK, et al. Sulforaphane atte-nuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β / Smad signaling[J]. Free Radic Biol Med, 2012, 52 (3): 671-682.
|
24 |
Bao B, Zhang MQ, Chen ZY, et al. Sulforaphane prevents PC12 cells from oxidative damage via the Nrf2 pathway[J]. Mol Med Rep, 2019, 19 (6): 4890-4896.
|
25 |
汤鲁明,王林霞,孙来芳,等. 萝卜硫素对脓毒症急性肺损伤大鼠氧化损伤及APE1表达的影响[J/CD]. 中华危重症医学杂志(电子版),2017,10(4):246-251.
|
26 |
徐建国,金献冠,李钰. 尿肾损伤分子1和中性粒细胞明胶酶相关脂质运载蛋白对脓毒症合并急性肾损伤患者早期连续性肾脏替代治疗的预测价值[J/CD]. 中华危重症医学杂志(电子版),2016,9(4):250-255.
|